Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bank of America Co. stock logo
BAC
Bank of America
$37.56
-0.7%
$36.13
$24.96
$38.49
$296.37B1.3941.26 million shs26.55 million shs
Citigroup Inc. stock logo
C
Citigroup
$62.26
-0.6%
$59.09
$38.17
$63.90
$119.24B1.5216.97 million shs11.30 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$146.82
+0.5%
$155.26
$143.13
$175.97
$353.80B0.537.36 million shs6.18 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bank of America Co. stock logo
BAC
Bank of America
0.00%+2.33%-0.24%+12.52%+29.20%
Citigroup Inc. stock logo
C
Citigroup
0.00%+5.95%-0.92%+15.80%+33.12%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%-1.20%-7.62%-8.28%-10.73%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bank of America Co. stock logo
BAC
Bank of America
4.7166 of 5 stars
2.25.02.53.33.11.72.5
Citigroup Inc. stock logo
C
Citigroup
4.903 of 5 stars
2.35.02.52.61.41.75.0
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9376 of 5 stars
3.23.04.23.93.82.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bank of America Co. stock logo
BAC
Bank of America
2.47
Hold$38.532.57% Upside
Citigroup Inc. stock logo
C
Citigroup
2.56
Moderate Buy$62.911.06% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8619.78% Upside

Current Analyst Ratings

Latest JNJ, BAC, and C Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/19/2024
Bank of America Co. stock logo
BAC
Bank of America
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$42.00
4/18/2024
Bank of America Co. stock logo
BAC
Bank of America
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$36.00 ➝ $37.00
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Bank of America Co. stock logo
BAC
Bank of America
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$46.00 ➝ $45.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/15/2024
Citigroup Inc. stock logo
C
Citigroup
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$67.00 ➝ $70.00
4/15/2024
Citigroup Inc. stock logo
C
Citigroup
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$88.00 ➝ $87.00
4/15/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$215.00
4/8/2024
Bank of America Co. stock logo
BAC
Bank of America
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$36.00 ➝ $39.00
(Data available from 4/29/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bank of America Co. stock logo
BAC
Bank of America
$171.91B1.72$3.88 per share9.67$33.26 per share1.13
Citigroup Inc. stock logo
C
Citigroup
$156.82B0.76$8.74 per share7.12$98.57 per share0.63
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.15$13.73 per share10.69$28.57 per share5.14

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bank of America Co. stock logo
BAC
Bank of America
$26.52B$2.8913.0010.921.6913.94%10.88%0.89%7/16/2024 (Estimated)
Citigroup Inc. stock logo
C
Citigroup
$9.23B$3.3818.428.710.944.90%6.17%0.49%7/12/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.1513.432.4145.26%36.43%15.01%7/18/2024 (Estimated)

Latest JNJ, BAC, and C Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2024Q1 24
Bank of America Co. stock logo
BAC
Bank of America
$0.77$0.83+$0.06$0.90$25.49 billion$25.82 billion    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
4/12/2024Q1 2024
Citigroup Inc. stock logo
C
Citigroup
$1.29$1.58+$0.29$1.58$20.46 billion$21.10 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bank of America Co. stock logo
BAC
Bank of America
$0.962.56%+8.51%33.22%3 Years
Citigroup Inc. stock logo
C
Citigroup
$2.123.41%+0.65%62.72%1 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.24%+5.70%29.68%63 Years

Latest JNJ, BAC, and C Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/25/2024
Bank of America Co. stock logo
BAC
Bank of America
quarterly$0.242.53%6/7/20246/7/20246/28/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
4/3/2024
Citigroup Inc. stock logo
C
Citigroup
quarterly$0.533.44%5/3/20245/6/20245/24/2024
1/31/2024
Bank of America Co. stock logo
BAC
Bank of America
quarterly$0.242.82%2/29/20243/1/20243/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bank of America Co. stock logo
BAC
Bank of America
1.12
0.79
0.79
Citigroup Inc. stock logo
C
Citigroup
1.50
0.95
0.95
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bank of America Co. stock logo
BAC
Bank of America
70.71%
Citigroup Inc. stock logo
C
Citigroup
71.72%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
Bank of America Co. stock logo
BAC
Bank of America
0.29%
Citigroup Inc. stock logo
C
Citigroup
0.08%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bank of America Co. stock logo
BAC
Bank of America
213,0007.89 billion7.87 billionOptionable
Citigroup Inc. stock logo
C
Citigroup
239,0001.92 billion1.91 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable

JNJ, BAC, and C Headlines

SourceHeadline
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiationsJudge rejects J&J, Bristol Myers Squibb challenges to Medicare drug price negotiations
cnbc.com - April 29 at 6:22 PM
J&J, Bristol Myers lose challenges to US drug price negotiation programJ&J, Bristol Myers lose challenges to US drug price negotiation program
reuters.com - April 29 at 5:57 PM
Cutting Edge Picks: 3 Med Tech Stocks With Room to RunCutting Edge Picks: 3 Med Tech Stocks With Room to Run
investorplace.com - April 29 at 5:07 PM
Johnson & Johnson (NYSE:JNJ) Trading 0.1% Higher Johnson & Johnson (NYSE:JNJ) Trading 0.1% Higher
marketbeat.com - April 29 at 3:17 PM
Johnson & Johnson-Partnered Addex Therapeutics Epilepsy Candidate Fails Mid-Stage Study, Stock TanksJohnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks
finance.yahoo.com - April 29 at 1:56 PM
Johnson & Johnson Is a King of Dividend SafetyJohnson & Johnson Is a King of Dividend Safety
fool.com - April 29 at 10:23 AM
7 Retirement Stocks to Buy at a 52-Week Low in April7 Retirement Stocks to Buy at a 52-Week Low in April
investorplace.com - April 29 at 10:03 AM
Schnieders Capital Management LLC Decreases Stock Position in Johnson & Johnson (NYSE:JNJ)Schnieders Capital Management LLC Decreases Stock Position in Johnson & Johnson (NYSE:JNJ)
marketbeat.com - April 29 at 6:16 AM
Neo Ivy Capital Management Acquires New Holdings in Johnson & Johnson (NYSE:JNJ)Neo Ivy Capital Management Acquires New Holdings in Johnson & Johnson (NYSE:JNJ)
marketbeat.com - April 28 at 10:34 PM
2 Top Growth Stocks to Buy Right Now and Hold Forever2 Top Growth Stocks to Buy Right Now and Hold Forever
fool.com - April 28 at 8:45 AM
Better Dividend Stock: AbbVie or Johnson & Johnson?Better Dividend Stock: AbbVie or Johnson & Johnson?
fool.com - April 28 at 4:20 AM
Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.1%Johnson & Johnson (NYSE:JNJ) Stock Price Down 0.1%
americanbankingnews.com - April 28 at 3:16 AM
PFG Investments LLC Buys 88,707 Shares of Johnson & Johnson (NYSE:JNJ)PFG Investments LLC Buys 88,707 Shares of Johnson & Johnson (NYSE:JNJ)
marketbeat.com - April 27 at 9:48 PM
Johnson & Johnson Stock: Buy, Sell, or Hold?Johnson & Johnson Stock: Buy, Sell, or Hold?
fool.com - April 27 at 7:45 AM
Generational Wealth Builders: 3 Stocks to Own for Decades of GainsGenerational Wealth Builders: 3 Stocks to Own for Decades of Gains
investorplace.com - April 27 at 6:00 AM
JNJ Receives Positive CHMP Opinion For Rybrevant For Treatment Of Patients With Advanced NSCLCJNJ Receives Positive CHMP Opinion For Rybrevant For Treatment Of Patients With Advanced NSCLC
markets.businessinsider.com - April 26 at 8:11 PM
Are You Looking for a High-Growth Dividend Stock?Are You Looking for a High-Growth Dividend Stock?
zacks.com - April 26 at 12:45 PM
5 Stocks in Focus on Their Recent Dividend Hike5 Stocks in Focus on Their Recent Dividend Hike
zacks.com - April 26 at 9:16 AM
Calamos Wealth Management LLC Has $4.82 Million Holdings in Johnson & Johnson (NYSE:JNJ)Calamos Wealth Management LLC Has $4.82 Million Holdings in Johnson & Johnson (NYSE:JNJ)
marketbeat.com - April 26 at 6:13 AM
Johnson & Johnson (NYSE:JNJ)  Shares Down 1.1% Johnson & Johnson (NYSE:JNJ) Shares Down 1.1%
marketbeat.com - April 25 at 6:18 PM
LLY vs. JNJ: Which Big Pharma Stock Is Better?LLY vs. JNJ: Which Big Pharma Stock Is Better?
msn.com - April 25 at 11:47 AM
Johnson & Johnsons (NYSE:JNJ) Dividend Will Be Increased To $1.24Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.24
finance.yahoo.com - April 25 at 11:47 AM
Johnson & Johnson (NYSE:JNJ) Stock Holdings Lessened by Cornerstone Investment Partners LLCJohnson & Johnson (NYSE:JNJ) Stock Holdings Lessened by Cornerstone Investment Partners LLC
marketbeat.com - April 25 at 5:42 AM
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.6%Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.6%
marketbeat.com - April 24 at 4:21 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bank of America logo

Bank of America

NYSE:BAC
Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small and middle-market businesses, institutional investors, large corporations, and governments worldwide. It operates in four segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking, and Global Markets. The Consumer Banking segment offers traditional and money market savings accounts, certificates of deposit and IRAs, non-interest and interest-bearing checking accounts, and investment accounts and products; credit and debit cards; residential mortgages, and home equity loans; and direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The GWIM segment provides investment management, brokerage, banking, and trust and retirement products and services; wealth management solutions; and customized solutions, including specialty asset management services. The Global Banking segment offers lending products and services, including commercial loans, leases, commitment facilities, trade finance, and commercial real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, short-term investing options, and merchant services; working capital management solutions; debt and equity underwriting and distribution, and merger-related and other advisory services; and fixed-income and equity research, and certain market-based services. The Global Markets segment provides market-making, financing, securities clearing, settlement, and custody services; securities and derivative products; and risk management products using interest rate, equity, credit, currency and commodity derivatives, foreign exchange, fixed-income, and mortgage-related products. Bank of America Corporation was founded in 1784 and is based in Charlotte, North Carolina.
Citigroup logo

Citigroup

NYSE:C
Citigroup Inc., a diversified financial service holding company, provides various financial product and services to consumers, corporations, governments, and institutions worldwide. It operates through five segments: Services, Markets, Banking, U.S. Personal Banking, and Wealth. The Services segment includes Treasury and Trade Solutions, which provides cash management, trade, and working capital solutions to multinational corporations, financial institutions, and public sector organizations; and Securities Services, such as cross-border support for clients, local market expertise, post-trade technologies, data solutions, and various securities services solutions. The Markets segment offers sales and trading services for equities, foreign exchange, rates, spread products, and commodities to corporate, institutional, and public sector clients; and market-making services, including asset classes, risk management solutions, financing, prime brokerage, research, securities clearing, and settlement. The banking segment includes investment banking; advisory services related to mergers and acquisitions, divestitures, restructurings, and corporate defense activities; and corporate lending, which includes corporate and commercial banking. The U.S. Personal Banking segment provides co-branded cards and retail banking services. The Wealth segment provides financial services to high-net-worth clients through banking, lending, mortgages, investment, custody, and trust product offerings; and to professional industries, including law firms, consulting groups, accounting, and asset management. The company was founded in 1812 and is headquartered in New York, New York.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.